Age related macular degeneration pharmacogenetics study
Completed
- Conditions
- Topic: EyeSubtopic: Eye (all Subtopics)Disease: OphthalmologyEye DiseasesAge related macular degeneration
- Registration Number
- ISRCTN44202629
- Lead Sponsor
- eeds Teaching Hospitals NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
1. Aged over 65 years, either sex
2. Affected with ARM
3. Currently under treatment with ranibizumab (Lucentis)
4. Patients with lesions of greatest linear diameter less than 5400 microns
Exclusion Criteria
1. Patients with poor general health
2. Patients with other eye pathology likely to affect response to treatment
3. Patients with lesions of greatest linear diameter greater than 5400 microns
4. Patients currently being treated with other anti-VEGF agents (systemic or ocular)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method